Mediclinic International PLC (MDCM.L)
MDCM.L on London Stock Exchange
315.60GBp
17 Dec 2018
315.60GBp
17 Dec 2018
Change (% chg)
-10.90 (-3.34%)
-10.90 (-3.34%)
Prev Close
326.50
326.50
Open
327.70
327.70
Day's High
327.70
327.70
Day's Low
315.60
315.60
Volume
75,237
75,237
Avg. Vol
2,241,854
2,241,854
52-wk High
712.40
712.40
52-wk Low
315.60
315.60
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2019 | Sep | 1,387.00 | -0.228 |
| FY 2018 | Mar '18 | 1,465.00 | -0.600 |
| Sep | 1,405.00 | -0.068 | |
| FY 2017 | Mar '17 | 1,466.00 | 0.161 |
| Sep | 1,283.00 | 0.149 | |
| FY 2016 | Mar '16 | 1,097.00 | 0.124 |
| Sep | 1,010.00 | 0.173 |
*Note: Units in Millions ofBritish Pounds
**Note: Units in British Pounds
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Year Ending Mar-18 | 11 | 2,871.38 | 2,989.00 | 2,802.20 | -- |
| Year Ending Mar-19 | 12 | 2,930.03 | 2,997.00 | 2,863.80 | 2,916.26 |
| Year Ending Mar-20 | 12 | 3,067.83 | 3,213.48 | 2,926.50 | 3,048.55 |
| Earnings (per share) | |||||
| Year Ending Mar-18 | 10 | 29.18 | 31.24 | 22.20 | -- |
| Year Ending Mar-19 | 13 | 26.35 | 30.16 | 24.00 | 32.30 |
| Year Ending Mar-20 | 13 | 29.65 | 36.46 | 26.39 | 35.03 |
| LT Growth Rate (%) | 2 | 5.52 | 11.90 | -0.86 | 7.40 |
Sales and Profit Figures in British Pound (GBP);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | 22.09 | 27.64 | 34.39 | |
| P/E High - Last 5 Yrs. | -- | 113.02 | 46.24 | |
| P/E Low - Last 5 Yrs. | -- | 20.68 | 24.59 | |
| Beta | 1.03 | 0.61 | 0.91 | |
| Price to Sales (TTM) | 1.84 | 15.52 | 6.22 | |
| Price to Book (MRQ) | 1.24 | 3.90 | 5.20 | |
| Price to Tangible Book (MRQ) | 2.62 | 4.50 | 6.74 | |
| Price to Cash Flow (TTM) | 13.03 | 16.40 | 24.17 | |
| % Owned Institutions | -- | 7.70 | 1.78 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 1.04 | 1.44 | |
| Dividend Yield - 5 Year Avg | -- | 0.83 | 1.46 | |
| Dividend 5 Year Growth Rate | -- | 10.42 | 4.94 | |
| Payout Ratio(TTM) | 25.43 | 13.98 | 42.49 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | 33.64 | 10.74 | 8.17 | |
| Sales (TTM) vs TTM 1 Yr. Ago | 30.47 | 9.56 | 6.50 | |
| Sales - 5 Yr. Growth Rate | -- | 14.84 | 10.44 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | 29.83 | 57.90 | 23.09 | |
| EPS (TTM) vs TTM 1 Yr. Ago | 4.44 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 10.73 | 10.49 | |
| Capital Spending - 5 Yr. Growth Rate | -- | 22.70 | 14.59 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | 1.66 | 7.91 | 2.28 |
| Current Ratio (MRQ) | 1.81 | 8.18 | 3.10 |
| LT Debt to Equity (MRQ) | 47.99 | 49.26 | 11.49 |
| Total Debt to Equity (MRQ) | 49.68 | 60.49 | 16.03 |
| Interest Coverage (TTM) | 6.42 | 36.67 | 30.57 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | 38.30 | 39.25 | 54.44 | |
| Gross Margin - 5 Yr. Avg. | -- | 40.34 | 52.36 | |
| EBITD Margin (TTM) | 18.52 | -- | -- | |
| EBITD - 5 Yr. Avg | -- | 2.43 | 13.16 | |
| Operating Margin (TTM) | 13.17 | -1.02 | 6.07 | |
| Operating Margin - 5 Yr. Avg. | -- | -7.54 | 8.47 | |
| Pre-Tax Margin (TTM) | 11.17 | 7.11 | 7.02 | |
| Pre-Tax Margin - 5 Yr. Avg. | -- | 1.38 | 8.71 | |
| Net Profit Margin (TTM) | 8.84 | 4.25 | 3.12 | |
| Net Profit Margin - 5 Yr. Avg. | -- | -1.23 | 4.91 | |
| Effective Tax Rate (TTM) | 20.85 | 19.79 | 23.26 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 38.04 | 23.83 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 93,364 | 6,383,856 | 873,051,409 | |
| Net Income/Employee (TTM) | 8,253 | -764,666 | 103,483,755 | |
| Receivable Turnover (TTM) | -- | 7.83 | 5.80 | |
| Inventory Turnover (TTM) | -- | 69.04 | 3.56 | |
| Asset Turnover (TTM) | -- | 0.62 | 0.95 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -- | 5.31 | 11.45 | |
| Return on Assets - 5 Yr. Avg. | -- | 6.04 | 12.50 | |
| Return on Investment (TTM) | -- | 6.83 | 14.96 | |
| Return on Investment - 5 Yr. Avg. | -- | 7.63 | 16.23 | |
| Return on Equity (TTM) | -- | 10.77 | 16.52 | |
| Return on Equity - 5 Yr. Avg. | -- | 11.44 | 17.37 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | 30.47 | -- | -- |
| EPS (TTM) % | 5.16 | -- | -- |
| Dividend % | 0.00 | -- | -- |
Note: Units in Millions of US Dollars
Performance for Mediclinic International PLC
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | -8.41 | -10.29 | 54 | 24 |
| 13 Week | -6.16 | -8.59 | 99 | 34 |
| 26 Week | -1.93 | -4.73 | 99 | 18 |
| 52 Week | -22.83 | -28.81 | 80 | 14 |
| YTD | -11.02 | -16.52 | 99 | 11 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 39.98% |
| # of Holders: | 264 |
| Total Shares Held: | 294,723,655 |
| 3 Mo. Net Change: | -1,314,322 |
| # New Positions: | 14 |
| # Closed Positions: | 22 |
| # Increased Positions: | 66 |
| # Reduced Positions: | 64 |
| # Net Buyers: | 2 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.